Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-014908
Filing Date
2017-02-27
Accepted
2017-02-27 17:32:05
Documents
1
Period of Report
2017-02-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 20830
  Complete submission text file 0001209191-17-014908.txt   22298
Mailing Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149
Business Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149 919-576-2306
CEMPRA, INC. (Issuer) CIK: 0001461993 (see all company filings)

EIN.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6320 QUADRANGLE DRIVE, SUITE 360 CHAPEL HILL NC 27517
Business Address
Oldach David W. (Reporting) CIK: 0001630330 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35405 | Film No.: 17643451